Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
Authors
Keywords
-
Journal
Cancer Medicine
Volume 9, Issue 15, Pages 5570-5586
Publisher
Wiley
Online
2020-06-10
DOI
10.1002/cam4.3210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3
- (2019) Lina Wang et al. ONCOGENE
- KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program
- (2019) Yanmin Xu et al. CANCER LETTERS
- KIAA1199, a Target of MicoRNA-486-5p, Promotes Papillary Thyroid Cancer Invasion by Influencing Epithelial-Mesenchymal Transition (EMT)
- (2019) Xuehua Jiao et al. MEDICAL SCIENCE MONITOR
- Clinical Significance of KIAA1199 as a Novel Target for Gastric Cancer Drug Therapy
- (2019) MASATAKA ONEYAMA et al. ANTICANCER RESEARCH
- CRF1 Receptor Signaling via the ERK1/2-MAP and Akt Kinase Cascades: Roles of Src, EGF Receptor, and PI3-Kinase Mechanisms
- (2019) G. Karina Parra-Mercado et al. Frontiers in Endocrinology
- Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms
- (2018) Chunmei Li et al. BMC CANCER
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer
- (2018) Junfeng Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway
- (2018) Lei Zhao et al. ONCOGENE
- Role of miR‐486‐5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF‐β–activated kinase 1
- (2018) Yanfa He et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT
- (2018) Zhiyuan Tang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer
- (2017) Dejun Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma
- (2017) Atsuhiro Koga et al. PANCREATOLOGY
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- (2017) et al. JAMA Oncology
- KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer
- (2017) Shuqin Jia et al. PLoS One
- Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma
- (2016) Yunfeng Yi et al. Experimental and Therapeutic Medicine
- EGFR and NF-κB: partners in cancer
- (2015) Kateryna Shostak et al. TRENDS IN MOLECULAR MEDICINE
- Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP)
- (2015) Nikki A. Evensen et al. Oncotarget
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- The Regulatory Role of MicroRNAs in EMT and Cancer
- (2015) Apostolos Zaravinos Journal of Oncology
- Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness
- (2014) Mohammad-Saeid Jami et al. BMC CANCER
- KIAA1199 and its biological role in human cancer and cancer cells (Review)
- (2014) YONGSHENG ZHANG et al. ONCOLOGY REPORTS
- NF-κB-induced KIAA1199 promotes survival through EGFR signalling
- (2014) Kateryna Shostak et al. Nature Communications
- miR-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non-Small Cell Lung Cancer
- (2013) J. Cai et al. CANCER RESEARCH
- Unraveling the Role of KIAA1199, a Novel Endoplasmic Reticulum Protein, in Cancer Cell Migration
- (2013) Nikki A. Evensen et al. JNCI-Journal of the National Cancer Institute
- Control of metastatic progression by microRNA regulatory networks
- (2013) Nora Pencheva et al. NATURE CELL BIOLOGY
- Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer
- (2013) J Wang et al. ONCOGENE
- Early Insights into the Function of KIAA1199, a Markedly Overexpressed Protein in Human Colorectal Tumors
- (2013) Amit Tiwari et al. PLoS One
- Age is a prognostic factor affecting survival in lung cancer patients
- (2013) FARUK TAS et al. Oncology Letters
- Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer
- (2012) Vassiliki Papadimitrakopoulou Journal of Thoracic Oncology
- Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells
- (2011) K Birkenkamp-Demtroder et al. BRITISH JOURNAL OF CANCER
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now